White and gray matter alterations in adults with Niemann-Pick disease type C
A cross-sectional study
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective: Niemann-Pick disease type C (NPC) is a progressive neurovisceral disorder with disrupted intracellular cholesterol metabolism that results in significant alterations to neuronal and axonal structure. Adult patients present with ataxia, gaze palsy, impaired cognition, and neuropsychiatric illness, but the neural substrate has not been well-characterized in vivo. Our aim was to investigate a well-characterized sample of adults with confirmed NPC for gray and white matter abnormalities.
Methods: We utilized a combination of optimized voxel-based morphometry of T1-weighted images and tract-based spatial statistics of diffusion tensor images to examine gray matter volume and white matter structural differences in 6 adult patients with NPC and 18 gender- and age-matched controls.
Results: Patients with NPC demonstrated bilateral gray matter reductions in large clusters in bilateral hippocampus, thalamus, superior cerebellum, and insula, in addition to smaller regions of inferoposterior cortex. Patients demonstrated widespread reductions in fractional anisotropy in major white matter tracts. Subsequent analysis of measures of axial and radial diffusivity suggest that these changes are contributed to by both impaired myelination and altered axonal structure.
Conclusions: Findings in gray matter areas are broadly consistent with human and animal studies of selective vulnerability of neuronal populations to the neuropathology of NPC, whereas more widespread white matter changes are consistent with the hypothesis that disrupted myelination and axonal structure predate changes to the neuronal cell body. These findings suggest that volumetric analysis of gray matter and diffusion tensor imaging may be useful modalities for indexing illness stage and monitoring response to emerging treatment.
Footnotes
-
Supplemental data at www.neurology.org
e-Pub ahead of print on May 19, 2010, at www.neurology.org.
Study funding: Supported by a Pfizer Neuroscience Research Grant (to M.W.).
Disclosure: Author disclosures are provided at the end of the article.
Received November 21, 2009. Accepted in final form February 23, 2010.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
- White and gray matter alterations in adults with Niemann-Pick disease type C: A cross-sectional stud
- Michael Scheel, University of British Columbia, Vancouver General Hospital Eye Care Centre, 2550 Willow Street, Vancouver, B.C. Canada V5Z 3N9mscheel@eyecarecentre.org
- Mathias Abegg (mabegg@eyecarecentre.org), Linda J Lanyon (llanyon@eyecarecentre.org), Andre Mattman (AMattman@providencehealth.bc.ca), Jason J Barton (jasonbarton@show.ca)
Submitted September 16, 2010 - Reply from the authors
- Mark A. Walterfang, Neuropsychiatry Unit, Royal Melbourne Hospital, Level 2, John-Cade Building, Royal Melbourne Hospitalmark.walterfang@mh.org.au
- Michael Fahey (mcfahey@mac.com), Amanda Wood (amanda.wood@mcri.edu.au), Patricia Desmond (patricia.desmond@mh.org.au), Dennis Velakoulis (dennis.velakoulis@mh.org.au)
Submitted September 16, 2010
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Long-term Safety and Efficacy of Avalglucosidase Alfa in Patients With Late-Onset Pompe Disease
Dr. Marianne de Visser and Dr. Maudy Theunissen
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Article
Imaging of neuroinflammation in adult Niemann-Pick type C diseaseA cross-sectional studyMark Walterfang, Maria A. Di Biase, Vanessa L. Cropley et al.Neurology, March 24, 2020 -
Article
White matter abnormalities in the corpus callosum with cognitive impairment in Parkinson diseaseIan O. Bledsoe, Glenn T. Stebbins, Doug Merkitch et al.Neurology, November 14, 2018 -
Article
Cognition and gray and white matter characteristics of presymptomatic C9orf72 repeat expansionJanne M. Papma, Lize C. Jiskoot, Jessica L. Panman et al.Neurology, August 30, 2017 -
Article
Cognitive impairment in MSImpact of white matter integrity, gray matter volume, and lesionsHanneke E. Hulst, Martijn D. Steenwijk, Adriaan Versteeg et al.Neurology, March 06, 2013